The impact of the COVID-19 pandemic on cancer care
- 20 May 2020
- journal article
- editorial
- Published by Springer Science and Business Media LLC in Nature Cancer
- Vol. 1 (6), 565-567
- https://doi.org/10.1038/s43018-020-0074-y
Abstract
The COVID-19 pandemic has disrupted the spectrum of cancer care, including delaying diagnoses and treatment and halting clinical trials. In response, healthcare systems are rapidly reorganizing cancer services to ensure that patients continue to receive essential care while minimizing exposure to SARS-CoV-2 infection.Keywords
This publication has 12 references indexed in Scilit:
- Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, ChinaAnnals of Oncology, 2020
- Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in ChinaJAMA, 2020
- Practice of endoscopy during COVID-19 pandemic: position statements of the Asian Pacific Society for Digestive Endoscopy (APSDE-COVID statements)Gut, 2020
- COVID-19: combining antiviral and anti-inflammatory treatmentsThe Lancet Infectious Diseases, 2020
- Infection Control of 2019 Novel Corona Virus Disease (COVID-19) in Cancer Patients undergoing Radiotherapy in WuhanPublished by Cold Spring Harbor Laboratory ,2020
- Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in ItalyJAMA, 2020
- Running a Radiation Oncology Department at the Time of Coronavirus: An Italian ExperienceAdvances in Radiation Oncology, 2020
- Prolonged presence of SARS-CoV-2 viral RNA in faecal samplesThe Lancet Gastroenterology & Hepatology, 2020
- Cancer patients in SARS-CoV-2 infection: a nationwide analysis in ChinaThe Lancet Oncology, 2020
- Key cost drivers of pharmaceutical clinical trials in the United StatesClinical Trials, 2016